Showing results (221-230 of 292) with videos related to

Sort By:
Pageof 30
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Nuclear Medicine Communications|November 8, 2022
Bone metastases in prostate cancer - Gallium-68-labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography - the better tracer?Archi Agrawal, Aravintho Natarajan, Sneha Mithun, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2024
Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of ProstateManeesh Singh, Priyamvada Maitre, Anuradha Krishnan, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Histopathology|September 29, 2021
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma - a validation on an external data setAkash P Sali, Gagan Prakash, Stênio de Cássio Zequi, et al.
Urologic Oncology|February 12, 2021
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, et al.
Indian Journal of Cancer|August 8, 2018
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaAmit Joshi, Amitesh Anand, Kumar Prabhash, et al.
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Clinical and Translational Radiation Oncology|December 24, 2025
Pre-PROTO-PRIME: stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer - feasibility, acute toxicity and dosimetric insightsSrinivas Chilukuri, Sham C Sundar, Vasanthapriya Subramani, et al.
Pageof 30